Search for other papers by Aglaia Kyrilli in
Google Scholar
PubMed
Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
Department of Gynecology and Obstetrics, Copenhagen University Hospital (Hvidovre Hospital), Hvidovre, Denmark
Search for other papers by Sofie Bliddal in
Google Scholar
PubMed
Carelink Nærhospital, Roskilde, Denmark
Search for other papers by Dorthe Hansen Precht in
Google Scholar
PubMed
Institute of Clinical Medicine, Faculty of Health and Clinical Research, Copenhagen University, Copenhagen, Denmark
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Université Libre de Bruxelles (ULB), Brussels, Belgium
Search for other papers by Kris Poppe in
Google Scholar
PubMed
deterioration in euthyroid women such as age, parity, BMI, TPOAb concentration, or initial TSH cutoff. Targeting the subgroup of women who could benefit the most from thyroid function monitoring during pregnancy could help to better identify ideal candidates for
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Louise Knøsgaard in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Aase Handberg in
Google Scholar
PubMed
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Steno Diabetes Center North Jutland, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Peter Vestergaard in
Google Scholar
PubMed
Department of Geriatrics, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
Introduction Maternal thyroid function in early pregnancy is a debated matter ( 1 , 2 ). The role of thyroid hormones in fetal brain development has long drawn ample attention to the potential adverse consequences of abnormal maternal thyroid
Search for other papers by Boni Xiang in
Google Scholar
PubMed
Search for other papers by Ran Tao in
Google Scholar
PubMed
Search for other papers by Xinhua Liu in
Google Scholar
PubMed
Search for other papers by Xiaoming Zhu in
Google Scholar
PubMed
Search for other papers by Min He in
Google Scholar
PubMed
Search for other papers by Zengyi Ma in
Google Scholar
PubMed
Search for other papers by Yehong Yang in
Google Scholar
PubMed
Search for other papers by Zhaoyun Zhang in
Google Scholar
PubMed
Search for other papers by Yiming Li in
Google Scholar
PubMed
Search for other papers by Zhenwei Yao in
Google Scholar
PubMed
Search for other papers by Yongfei Wang in
Google Scholar
PubMed
Search for other papers by Hongying Ye in
Google Scholar
PubMed
thyroid hormone changes was studied before and after remission of endogenous CS. In clinical practice, because of the lack of knowledge about this condition, some CS patients’ thyroid functions may be mistaken as evidence of hypothyroidism or
Search for other papers by Caroline Serrano-Nascimento in
Google Scholar
PubMed
Search for other papers by Rafael Barrera Salgueiro in
Google Scholar
PubMed
Search for other papers by Kaio Fernando Vitzel in
Google Scholar
PubMed
Search for other papers by Thiago Pantaleão in
Google Scholar
PubMed
Search for other papers by Vânia Maria Corrêa da Costa in
Google Scholar
PubMed
Search for other papers by Maria Tereza Nunes in
Google Scholar
PubMed
thyroid disorders ( 10 , 11 , 12 ). It is worth noting that the daily requirement of iodine consumption increases to 200–250 µg during pregnancy and lactation, in order to guarantee normal maternal thyroid function ( 13 ). Indeed, adequate maternal TH
Search for other papers by Xiaoya Zheng in
Google Scholar
PubMed
Search for other papers by Heng Xiao in
Google Scholar
PubMed
Search for other papers by Jian Long in
Google Scholar
PubMed
Search for other papers by Qiang Wei in
Google Scholar
PubMed
Search for other papers by Liping Liu in
Google Scholar
PubMed
Search for other papers by Liping Zan in
Google Scholar
PubMed
Search for other papers by Wei Ren in
Google Scholar
PubMed
-related adverse events (irAEs) ( 2 ). Among endocrine irAEs, thyroid dysfunction occurs most frequently in patients treated with anti-PD-1 therapy ( 3 , 4 ). The mechanism by which anti-PD-1 treatment causes abnormal thyroid function is not yet fully understood
Search for other papers by Giorgio Radetti in
Google Scholar
PubMed
Search for other papers by Mariacarolina Salerno in
Google Scholar
PubMed
Search for other papers by Chiara Guzzetti in
Google Scholar
PubMed
Search for other papers by Marco Cappa in
Google Scholar
PubMed
Search for other papers by Andrea Corrias in
Google Scholar
PubMed
Search for other papers by Alessandra Cassio in
Google Scholar
PubMed
Search for other papers by Graziano Cesaretti in
Google Scholar
PubMed
Search for other papers by Roberto Gastaldi in
Google Scholar
PubMed
Search for other papers by Mario Rotondi in
Google Scholar
PubMed
Search for other papers by Fiorenzo Lupi in
Google Scholar
PubMed
Search for other papers by Antonio Fanolla in
Google Scholar
PubMed
Search for other papers by Giovanna Weber in
Google Scholar
PubMed
Search for other papers by Sandro Loche in
Google Scholar
PubMed
Introduction Hashimoto’s thyroiditis (HT) is a frequent autoimmune disease that may present with a spectrum of altered thyroid function ranging from thyrotoxicosis to overt hypothyroidism. Treatment with l -thyroxine ( l -T4) is commonly
Search for other papers by Till Ittermann in
Google Scholar
PubMed
Department of Zoology, Islamia College Peshawar (CU), Peshawar, Pakistan
Search for other papers by Rehman Mehmood Khattak in
Google Scholar
PubMed
Search for other papers by Marcello R P Markus in
Google Scholar
PubMed
Search for other papers by Jens-Peter Kühn in
Google Scholar
PubMed
Search for other papers by Marie-Luise Kromrey in
Google Scholar
PubMed
Search for other papers by Giovanni Targher in
Google Scholar
PubMed
Search for other papers by Antje Steveling in
Google Scholar
PubMed
DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine, Greifswald, Germany
Search for other papers by Matthias Nauck in
Google Scholar
PubMed
Search for other papers by Henry Völzke in
Google Scholar
PubMed
contents via proton-density fat fraction (PDFF) and transverse relaxation rate (R2*), respectively ( 8 , 9 , 10 ). As far as we know, there are no population-based studies that investigated the associations of thyroid function parameters with NAFLD and
Search for other papers by W J Bom in
Google Scholar
PubMed
Search for other papers by F B M Joosten in
Google Scholar
PubMed
Search for other papers by M M G J van Borren in
Google Scholar
PubMed
Search for other papers by E P Bom in
Google Scholar
PubMed
Search for other papers by R R J P van Eekeren in
Google Scholar
PubMed
Search for other papers by H de Boer in
Google Scholar
PubMed
Introduction About 10% of the population has a benign non-functioning thyroid nodule (NFTN) of 1 cm or larger ( 1 ), and 4–7% of these nodules are symptomatic ( 2 , 3 , 4 ). Unilateral lobectomy and volume reduction by radioiodine (RAI) have
Search for other papers by Yanling Cai in
Google Scholar
PubMed
Search for other papers by Yan Yang in
Google Scholar
PubMed
Search for other papers by Xiao Pang in
Google Scholar
PubMed
Search for other papers by Suping Li in
Google Scholar
PubMed
male gonadal function. To retrieve all the relevant studies, the following descriptors were used to build the search strategies: radioactive iodine therapy, 131 I, iodine 131, RAI, iodine, radioisotope, iodine radioisotope, thyroid cancer, thyroid
Search for other papers by Hana Vítková in
Google Scholar
PubMed
Search for other papers by Kateřina Anderlová in
Google Scholar
PubMed
Search for other papers by Jan Krátký in
Google Scholar
PubMed
Search for other papers by Radovan Bílek in
Google Scholar
PubMed
Search for other papers by Drahomíra Springer in
Google Scholar
PubMed
Search for other papers by Felix Votava in
Google Scholar
PubMed
Search for other papers by Tomáš Brutvan in
Google Scholar
PubMed
Search for other papers by Adéla Krausová in
Google Scholar
PubMed
Search for other papers by Kristýna Žabková in
Google Scholar
PubMed
Search for other papers by Eliška Potluková in
Google Scholar
PubMed
Search for other papers by Jan Jiskra in
Google Scholar
PubMed
Introduction: Maternal urinary iodine concentration (UIC) and blood neonatal thyroid stimulating hormone (TSH) concentration reflect iodine status in pregnancy. As dietary measures in gestational diabetes mellitus (GDM) could affect iodine intake, our study aimed to investigate iodine supply in women with GDM compared to healthy pregnant women and to evaluate its relationship to thyroid function.
Methods: UIC and serum TSH, free thyroxine (FT4) and autoantibodies against thyroid peroxidase (TPOAb) were analysed in 195 women with GDM and 88 healthy pregnant women in the 2nd trimester. Subsequently, neonatal TSH concentrations measured 72 hours after delivery in a subgroup of 154 newborns (115 of mothers with GDM and 39 controls) from the national register were analysed.
Results: Optimal iodine intake was found only in nine women with GDM (4.6%) and 33 healthy pregnant women (37.5%) (P<0.001). Most pregnant women with GDM (88.7%) as compared to one half of controls (50%) had iodine deficiency (P<0.001). Also, hypothyroxinaemia was more prevalent in GDM compared to controls (12.3% vs 3.4%, P = 0.032). Consistently, neonatal TSH >5.0 mIU/L indicating iodine deficiency was found in 6 (5.2%) newborns of women with GDM as compared to none in controls. In the multiple logistic and linear regression models in women with GDM, hypothyroxinaemia was associated with preterm births, and a negative association of serum FT4 and HbA1c was found.
Conclusion: Iodine deficiency in pregnancy was more prevalent among women with GDM compared to healthy pregnant controls. Hypothyroxinaemia was associated with preterm births in women with GDM.